195 related articles for article (PubMed ID: 23361338)
1. Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors.
Villaseñor A; Ballard-Barbash R; Ambs A; Bernstein L; Baumgartner K; Baumgartner R; Ulrich CM; Hollis BW; McTiernan A; Neuhouser ML
Cancer Causes Control; 2013 Apr; 24(4):759-67. PubMed ID: 23361338
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors.
Neuhouser ML; Sorensen B; Hollis BW; Ambs A; Ulrich CM; McTiernan A; Bernstein L; Wayne S; Gilliland F; Baumgartner K; Baumgartner R; Ballard-Barbash R
Am J Clin Nutr; 2008 Jul; 88(1):133-9. PubMed ID: 18614733
[TBL] [Abstract][Full Text] [Related]
3. Serum vitamin D and breast density in breast cancer survivors.
Neuhouser ML; Bernstein L; Hollis BW; Xiao L; Ambs A; Baumgartner K; Baumgartner R; McTiernan A; Ballard-Barbash R
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):412-7. PubMed ID: 20086111
[TBL] [Abstract][Full Text] [Related]
4. Negative Impact of 25-hydroxyvitamin D Deficiency on Breast Cancer Survival.
Thanasitthichai S; Prasitthipayong A; Boonmark K; Purisa W; Guayraksa K
Asian Pac J Cancer Prev; 2019 Oct; 20(10):3101-3106. PubMed ID: 31653160
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Predictors of Low Serum 25-Hydroxyvitamin D among Female African-American Breast Cancer Survivors.
Sheean P; Arroyo C; Woo J; Schiffer L; Stolley M
J Acad Nutr Diet; 2018 Apr; 118(4):568-577. PubMed ID: 29305131
[TBL] [Abstract][Full Text] [Related]
6. Dietary fiber, carbohydrates, glycemic index, and glycemic load in relation to breast cancer prognosis in the HEAL cohort.
Belle FN; Kampman E; McTiernan A; Bernstein L; Baumgartner K; Baumgartner R; Ambs A; Ballard-Barbash R; Neuhouser ML
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):890-9. PubMed ID: 21430298
[TBL] [Abstract][Full Text] [Related]
7. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J
Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459
[TBL] [Abstract][Full Text] [Related]
8. Circulating 25-hydroxyvitamin D and survival in women with ovarian cancer.
Webb PM; de Fazio A; Protani MM; Ibiebele TI; Nagle CM; Brand AH; Blomfield PI; Grant P; Perrin LC; Neale RE;
Am J Clin Nutr; 2015 Jul; 102(1):109-14. PubMed ID: 25971716
[TBL] [Abstract][Full Text] [Related]
9. Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study.
Yao S; Kwan ML; Ergas IJ; Roh JM; Cheng TD; Hong CC; McCann SE; Tang L; Davis W; Liu S; Quesenberry CP; Lee MM; Ambrosone CB; Kushi LH
JAMA Oncol; 2017 Mar; 3(3):351-357. PubMed ID: 27832250
[TBL] [Abstract][Full Text] [Related]
10. Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study.
Vrieling A; Hein R; Abbas S; Schneeweiss A; Flesch-Janys D; Chang-Claude J
Breast Cancer Res; 2011 Jul; 13(4):R74. PubMed ID: 21791049
[TBL] [Abstract][Full Text] [Related]
11. The inverse association between serum 25-hydroxyvitamin D and mortality may be modified by vitamin A status and use of vitamin A supplements.
Schmutz EA; Zimmermann MB; Rohrmann S
Eur J Nutr; 2016 Feb; 55(1):393-402. PubMed ID: 25701092
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
McDonnell SL; Baggerly CA; French CB; Baggerly LL; Garland CF; Gorham ED; Hollis BW; Trump DL; Lappe JM
PLoS One; 2018; 13(6):e0199265. PubMed ID: 29906273
[TBL] [Abstract][Full Text] [Related]
13. Association of serum 25-hydroxy-vitamin D concentration and risk of mortality in cancer survivors in the United States.
Mo X; He C; Han F; Yan H; Chen X; Wang Y; Zhou M
BMC Cancer; 2024 Apr; 24(1):545. PubMed ID: 38689243
[TBL] [Abstract][Full Text] [Related]
14. 25-Hydroxyvitamin D at time of breast cancer diagnosis and breast cancer survival.
Kanstrup C; Teilum D; Rejnmark L; Bigaard JV; Eiken P; Kroman N; Tjønneland A; Mejdahl MK
Breast Cancer Res Treat; 2020 Feb; 179(3):699-708. PubMed ID: 31707511
[TBL] [Abstract][Full Text] [Related]
15. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
[TBL] [Abstract][Full Text] [Related]
16. Association between alterations in the serum 25-hydroxyvitamin d status during follow-up and breast cancer patient prognosis.
Lim ST; Jeon YW; Suh YJ
Asian Pac J Cancer Prev; 2015; 16(6):2507-13. PubMed ID: 25824788
[TBL] [Abstract][Full Text] [Related]
17. Serum 25-Hydroxyvitamin D Values and Risk of All-Cause and Cause-Specific Mortality: A Population-Based Cohort Study.
Dudenkov DV; Mara KC; Petterson TM; Maxson JA; Thacher TD
Mayo Clin Proc; 2018 Jun; 93(6):721-730. PubMed ID: 29730089
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study.
Villaseñor A; Ballard-Barbash R; Baumgartner K; Baumgartner R; Bernstein L; McTiernan A; Neuhouser ML
J Cancer Surviv; 2012 Dec; 6(4):398-406. PubMed ID: 23054848
[TBL] [Abstract][Full Text] [Related]
19. Use of complementary and alternative medicine and breast cancer survival in the Health, Eating, Activity, and Lifestyle Study.
Neuhouser ML; Smith AW; George SM; Gibson JT; Baumgartner KB; Baumgartner R; Duggan C; Bernstein L; McTiernan A; Ballard R
Breast Cancer Res Treat; 2016 Dec; 160(3):539-546. PubMed ID: 27766453
[TBL] [Abstract][Full Text] [Related]
20. Relationship of very low serum 25-hydroxyvitamin D
Maalmi H; Walter V; Jansen L; Chang-Claude J; Owen RW; Ulrich A; Schöttker B; Hoffmeister M; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):961-971. PubMed ID: 28884317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
